Matches in Nanopublications for { ?s ?p "[Inhibition of JAK-2 phosphorylation might occur through SHP-1-dependent pathways, indicating that hyperinsulinaemia contributes to the pathogenesis of leptin resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP233144.RAoz2J7Fs_EEMehP8wyY4uk_8X6RN-DnnNE029yCFRvN4130_assertion description "[Inhibition of JAK-2 phosphorylation might occur through SHP-1-dependent pathways, indicating that hyperinsulinaemia contributes to the pathogenesis of leptin resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP233144.RAoz2J7Fs_EEMehP8wyY4uk_8X6RN-DnnNE029yCFRvN4130_provenance.
- NP590037.RAKpRv9cNxyl9TmqYk9apyRRn_mkc5_0x9vcVZ6qLqjcc130_assertion description "[Inhibition of JAK-2 phosphorylation might occur through SHP-1-dependent pathways, indicating that hyperinsulinaemia contributes to the pathogenesis of leptin resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP590037.RAKpRv9cNxyl9TmqYk9apyRRn_mkc5_0x9vcVZ6qLqjcc130_provenance.
- assertion description "[Inhibition of JAK-2 phosphorylation might occur through SHP-1-dependent pathways, indicating that hyperinsulinaemia contributes to the pathogenesis of leptin resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inhibition of JAK-2 phosphorylation might occur through SHP-1-dependent pathways, indicating that hyperinsulinaemia contributes to the pathogenesis of leptin resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP332894.RAb_E6zOBfLZx65SAbw2cA7AEqJ0qXqS9eMshuagbXRnw130_assertion description "[Inhibition of JAK-2 phosphorylation might occur through SHP-1-dependent pathways, indicating that hyperinsulinaemia contributes to the pathogenesis of leptin resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332894.RAb_E6zOBfLZx65SAbw2cA7AEqJ0qXqS9eMshuagbXRnw130_provenance.
- NP795884.RApsuj4LgrwqhwbUP_ZezWnz6J3nMaxyi_cYGZcVZE244130_assertion description "[Inhibition of JAK-2 phosphorylation might occur through SHP-1-dependent pathways, indicating that hyperinsulinaemia contributes to the pathogenesis of leptin resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795884.RApsuj4LgrwqhwbUP_ZezWnz6J3nMaxyi_cYGZcVZE244130_provenance.
- NP332891.RAks79EqRTjjlH0Y2nyWh9lzWqdquOEJVkBanzaa6Aw-0130_assertion description "[Inhibition of JAK-2 phosphorylation might occur through SHP-1-dependent pathways, indicating that hyperinsulinaemia contributes to the pathogenesis of leptin resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332891.RAks79EqRTjjlH0Y2nyWh9lzWqdquOEJVkBanzaa6Aw-0130_provenance.
- NP660126.RA-Q_eQH2P0SWfDHneNUAzkhoLJHnLtMyKSXsQvgn7Sis130_assertion description "[Inhibition of JAK-2 phosphorylation might occur through SHP-1-dependent pathways, indicating that hyperinsulinaemia contributes to the pathogenesis of leptin resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660126.RA-Q_eQH2P0SWfDHneNUAzkhoLJHnLtMyKSXsQvgn7Sis130_provenance.